These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
332 related articles for article (PubMed ID: 17241879)
1. STAT3 is required for IL-6-gp130-dependent activation of hepcidin in vivo. Pietrangelo A; Dierssen U; Valli L; Garuti C; Rump A; Corradini E; Ernst M; Klein C; Trautwein C Gastroenterology; 2007 Jan; 132(1):294-300. PubMed ID: 17241879 [TBL] [Abstract][Full Text] [Related]
2. Molecular dissection of gp130-dependent pathways in hepatocytes during liver regeneration. Dierssen U; Beraza N; Lutz HH; Liedtke C; Ernst M; Wasmuth HE; Trautwein C J Biol Chem; 2008 Apr; 283(15):9886-95. PubMed ID: 18216023 [TBL] [Abstract][Full Text] [Related]
3. STAT3 and STAT1 mediate IL-11-dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice. Ernst M; Najdovska M; Grail D; Lundgren-May T; Buchert M; Tye H; Matthews VB; Armes J; Bhathal PS; Hughes NR; Marcusson EG; Karras JG; Na S; Sedgwick JD; Hertzog PJ; Jenkins BJ J Clin Invest; 2008 May; 118(5):1727-38. PubMed ID: 18431520 [TBL] [Abstract][Full Text] [Related]
4. Hyperactivation of Stat3 in gp130 mutant mice promotes gastric hyperproliferation and desensitizes TGF-beta signaling. Jenkins BJ; Grail D; Nheu T; Najdovska M; Wang B; Waring P; Inglese M; McLoughlin RM; Jones SA; Topley N; Baumann H; Judd LM; Giraud AS; Boussioutas A; Zhu HJ; Ernst M Nat Med; 2005 Aug; 11(8):845-52. PubMed ID: 16041381 [TBL] [Abstract][Full Text] [Related]
5. IL-6 regulates neutrophil trafficking during acute inflammation via STAT3. Fielding CA; McLoughlin RM; McLeod L; Colmont CS; Najdovska M; Grail D; Ernst M; Jones SA; Topley N; Jenkins BJ J Immunol; 2008 Aug; 181(3):2189-95. PubMed ID: 18641358 [TBL] [Abstract][Full Text] [Related]
6. Pathologic consequences of STAT3 hyperactivation by IL-6 and IL-11 during hematopoiesis and lymphopoiesis. Jenkins BJ; Roberts AW; Greenhill CJ; Najdovska M; Lundgren-May T; Robb L; Grail D; Ernst M Blood; 2007 Mar; 109(6):2380-8. PubMed ID: 17082315 [TBL] [Abstract][Full Text] [Related]
7. Pretreatment with CO-releasing molecules suppresses hepcidin expression during inflammation and endoplasmic reticulum stress through inhibition of the STAT3 and CREBH pathways. Shin DY; Chung J; Joe Y; Pae HO; Chang KC; Cho GJ; Ryter SW; Chung HT Blood; 2012 Mar; 119(11):2523-32. PubMed ID: 22262759 [TBL] [Abstract][Full Text] [Related]
8. The IL-6-gp130-STAT3 pathway in hepatocytes triggers liver protection in T cell-mediated liver injury. Klein C; Wüstefeld T; Assmus U; Roskams T; Rose-John S; Müller M; Manns MP; Ernst M; Trautwein C J Clin Invest; 2005 Apr; 115(4):860-9. PubMed ID: 15761498 [TBL] [Abstract][Full Text] [Related]
9. Continuous glycoprotein-130-mediated signal transducer and activator of transcription-3 activation promotes inflammation, left ventricular rupture, and adverse outcome in subacute myocardial infarction. Hilfiker-Kleiner D; Shukla P; Klein G; Schaefer A; Stapel B; Hoch M; Müller W; Scherr M; Theilmeier G; Ernst M; Hilfiker A; Drexler H Circulation; 2010 Jul; 122(2):145-55. PubMed ID: 20585009 [TBL] [Abstract][Full Text] [Related]
10. Opposing roles of gp130-mediated STAT-3 and ERK-1/ 2 signaling in liver progenitor cell migration and proliferation. Yeoh GC; Ernst M; Rose-John S; Akhurst B; Payne C; Long S; Alexander W; Croker B; Grail D; Matthews VB Hepatology; 2007 Feb; 45(2):486-94. PubMed ID: 17256754 [TBL] [Abstract][Full Text] [Related]
11. Flavanoids induce expression of the suppressor of cytokine signalling 3 (SOCS3) gene and suppress IL-6-activated signal transducer and activator of transcription 3 (STAT3) activation in vascular endothelial cells. Wiejak J; Dunlop J; Mackay SP; Yarwood SJ Biochem J; 2013 Sep; 454(2):283-93. PubMed ID: 23782265 [TBL] [Abstract][Full Text] [Related]
12. The peroxisome proliferator-activated receptor (PPAR) β/δ agonist GW501516 inhibits IL-6-induced signal transducer and activator of transcription 3 (STAT3) activation and insulin resistance in human liver cells. Serrano-Marco L; Barroso E; El Kochairi I; Palomer X; Michalik L; Wahli W; Vázquez-Carrera M Diabetologia; 2012 Mar; 55(3):743-51. PubMed ID: 22179221 [TBL] [Abstract][Full Text] [Related]
13. Sustained submicromolar H2O2 levels induce hepcidin via signal transducer and activator of transcription 3 (STAT3). Millonig G; Ganzleben I; Peccerella T; Casanovas G; Brodziak-Jarosz L; Breitkopf-Heinlein K; Dick TP; Seitz HK; Muckenthaler MU; Mueller S J Biol Chem; 2012 Oct; 287(44):37472-82. PubMed ID: 22932892 [TBL] [Abstract][Full Text] [Related]
14. The threshold of gp130-dependent STAT3 signaling is critical for normal regulation of hematopoiesis. Jenkins BJ; Roberts AW; Najdovska M; Grail D; Ernst M Blood; 2005 May; 105(9):3512-20. PubMed ID: 15650055 [TBL] [Abstract][Full Text] [Related]
15. STAT3 activation in response to IL-6 is prolonged by the binding of IL-6 receptor to EGF receptor. Wang Y; van Boxel-Dezaire AH; Cheon H; Yang J; Stark GR Proc Natl Acad Sci U S A; 2013 Oct; 110(42):16975-80. PubMed ID: 24082147 [TBL] [Abstract][Full Text] [Related]
16. Iron-dependent CDK1 activity promotes lung carcinogenesis via activation of the GP130/STAT3 signaling pathway. Kuang Y; Guo W; Ling J; Xu D; Liao Y; Zhao H; Du X; Wang H; Xu M; Song H; Wang T; Jing B; Li K; Hu M; Wu W; Deng J; Wang Q Cell Death Dis; 2019 Apr; 10(4):297. PubMed ID: 30931929 [TBL] [Abstract][Full Text] [Related]
17. Critical and independent role for SOCS3 in either myeloid or T cells in resistance to Mycobacterium tuberculosis. Carow B; Reuschl AK; Gavier-Widén D; Jenkins BJ; Ernst M; Yoshimura A; Chambers BJ; Rottenberg ME PLoS Pathog; 2013; 9(7):e1003442. PubMed ID: 23853585 [TBL] [Abstract][Full Text] [Related]
18. Iron overload inhibits BMP/SMAD and IL-6/STAT3 signaling to hepcidin in cultured hepatocytes. Charlebois E; Pantopoulos K PLoS One; 2021; 16(6):e0253475. PubMed ID: 34161397 [TBL] [Abstract][Full Text] [Related]
19. STAT3 signaling within hepatocytes is required for anemia of inflammation in vivo. Sakamori R; Takehara T; Tatsumi T; Shigekawa M; Hikita H; Hiramatsu N; Kanto T; Hayashi N J Gastroenterol; 2010 Feb; 45(2):244-8. PubMed ID: 20091060 [TBL] [Abstract][Full Text] [Related]